Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 5/20 | 0.48 |
| ▸ | CTSL | P07711 | 4/20 | 0.48 |
| ▸ | CTSB | P07858 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CTSK | P43235 | 4/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2908157 | 0.90 | CTSS (0.50) | CTSSCTSLCTSBALDH1A1SMN1; SMN2 | |
| SCHEMBL2394738 | 0.88 | CTSS (0.55) | CTSSCTSLCTSBALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL29158022 | 0.87 | CTSS (0.54) | CTSSCTSLCTSBALDH1A1SMN1; SMN2 | |
| SCHEMBL7432792 | 0.85 | CTSS (0.62) | CTSSCTSLCTSBALDH1A1SMN1; SMN2 | |
| SCHEMBL2208865 | 0.85 | OPRD1 (0.47) | CTSSCTSLCTSBSMN1; SMN2CYP2C19 | |
| SCHEMBL25199383 | 0.85 | CTSS (0.51) | CTSSCTSLCTSBSMN1; SMN2DPP4 | |
| SCHEMBL25199386 | 0.85 | CTSS (0.51) | CTSSCTSLCTSBSMN1; SMN2DPP4 | |
| SCHEMBL6623440 | 0.84 | CTSS (0.65) | CTSSCTSLCTSBALDH1A1SMN1; SMN2 | |
| SCHEMBL26656819 | 0.82 | DPP4 (0.43) | CTSSCTSLCTSBSMN1; SMN2CYP2C19 | |
| SCHEMBL2796110 | 0.82 | CTSS (0.47) | CTSSCTSLCTSBSMN1; SMN2CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101090902-B | Cgrp receptor antagonists | MERCK SHARP & DOHME | 2013-05-29 | — | — | CN | disclosed |
| EP-1799672-B1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2013-01-02 | — | — | EP | disclosed |
| US-8039460-B2 | CGRP (Calcitonin Gene-Related Peptide); migraine and cluster headache; compounds based on 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine or 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine | MERCK SHARP & DOHME CORP. (US) | 2011-10-18 | — | — | US | disclosed |
| US-20100113419-A1 | CGRP RECEPTOR ANTAGONISTS | BURGEY CHRISTOPHER S | 2010-05-06 | — | — | US | disclosed |
| US-7659264-B2 | CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2010-02-09 | — | — | US | disclosed |
| US-20080113966-A1 | Cgrp Receptor Antagonists | MERCK SHARP & DOHME LLC | 2008-05-15 | — | — | US | disclosed |
| US-20080070899-A1 | Cgrp Receptor Antagonists | MERCK SHARP & DOHME LLC | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070899-A1 | Cgrp Receptor Antagonists | BDKRB1, CCKBR, CALCRL | CTSS 1409/4885CTSL 1815/4885CTSB 919/4885 |
| US-20080113966-A1 | Cgrp Receptor Antagonists | BDKRB1, BDKRB2, CCKBR | CTSS 1418/4885CTSL 1788/4885CTSB 661/4885 |
| US-20100113419-A1 | CGRP RECEPTOR ANTAGONISTS | BDKRB1, CCKBR, BDKRB2 | CTSS 1365/4885CTSL 1798/4885CTSB 845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.